PMC:7127386 / 4289-6209
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
169 | 0-10 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
170 | 18-25 | Species | denotes | BetaCoV | Tax:694002 |
171 | 136-143 | Species | denotes | patient | Tax:9606 |
172 | 503-509 | Species | denotes | stocks | Tax:3724 |
173 | 1118-1128 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
174 | 303-307 | Chemical | denotes | DMEM | |
175 | 336-343 | Chemical | denotes | glucose | MESH:D005947 |
176 | 354-369 | Chemical | denotes | sodium pyruvate | |
177 | 391-401 | Chemical | denotes | Penicillin | MESH:D010406 |
178 | 402-414 | Chemical | denotes | Streptomycin | MESH:D013307 |
179 | 426-431 | Chemical | denotes | HEPES | MESH:D006531 |
180 | 541-551 | Chemical | denotes | remdesivir | MESH:C000606551 |
181 | 749-758 | Chemical | denotes | lopinavir | MESH:D061466 |
182 | 785-790 | Chemical | denotes | water | MESH:D014867 |
183 | 905-928 | Chemical | denotes | Oseltamivir carboxylate | MESH:C535162 |
184 | 939-944 | Chemical | denotes | water | MESH:D014867 |
185 | 127-135 | Disease | denotes | COVID-19 | MESH:C000657245 |
186 | 286-295 | Disease | denotes | infection | MESH:D007239 |
187 | 1072-1081 | Disease | denotes | infection | MESH:D007239 |
188 | 1105-1114 | Disease | denotes | infection | MESH:D007239 |
189 | 1320-1329 | Disease | denotes | infection | MESH:D007239 |
190 | 168-170 | CellLine | denotes | E6 | CVCL:4582 |
191 | 274-276 | CellLine | denotes | E6 | CVCL:4582 |
192 | 1020-1022 | CellLine | denotes | E6 | CVCL:4582 |
193 | 1843-1845 | CellLine | denotes | E6 | CVCL:4582 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T6 | 75-86 | Body_part | denotes | nasopharynx | http://purl.org/sig/ont/fma/fma54878 |
T7 | 100-106 | Body_part | denotes | throat | http://purl.org/sig/ont/fma/fma228738 |
T8 | 171-176 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T9 | 277-282 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T10 | 336-343 | Body_part | denotes | glucose | http://purl.org/sig/ont/fma/fma82743 |
T11 | 1023-1028 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T12 | 1295-1300 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T13 | 1846-1851 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T14 | 1889-1893 | Body_part | denotes | Cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 75-86 | Body_part | denotes | nasopharynx | http://purl.obolibrary.org/obo/UBERON_0001728 |
T2 | 100-106 | Body_part | denotes | throat | http://purl.obolibrary.org/obo/UBERON_0000341 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T23 | 0-8 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T24 | 127-135 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T25 | 286-295 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T26 | 1072-1081 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T27 | 1105-1114 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T28 | 1118-1126 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T29 | 1320-1329 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T19 | 11-16 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T20 | 115-116 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T21 | 163-176 | http://purl.obolibrary.org/obo/CLO_0051719 | denotes | Vero E6 cells |
T22 | 200-205 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T23 | 269-282 | http://purl.obolibrary.org/obo/CLO_0051719 | denotes | Vero E6 cells |
T24 | 1015-1028 | http://purl.obolibrary.org/obo/CLO_0051719 | denotes | Vero E6 cells |
T25 | 1129-1134 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T26 | 1195-1200 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T27 | 1295-1300 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
T28 | 1372-1374 | http://purl.obolibrary.org/obo/CLO_0001382 | denotes | 48 |
T29 | 1513-1518 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | Virus |
T30 | 1838-1851 | http://purl.obolibrary.org/obo/CLO_0051719 | denotes | Vero E6 cells |
T31 | 1889-1893 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | Cell |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T60 | 334-343 | Chemical | denotes | D-glucose | http://purl.obolibrary.org/obo/CHEBI_17634|http://purl.obolibrary.org/obo/CHEBI_4167|http://purl.obolibrary.org/obo/CHEBI_42758 |
T63 | 336-343 | Chemical | denotes | glucose | http://purl.obolibrary.org/obo/CHEBI_17234 |
T64 | 354-369 | Chemical | denotes | sodium pyruvate | http://purl.obolibrary.org/obo/CHEBI_50144 |
T65 | 354-360 | Chemical | denotes | sodium | http://purl.obolibrary.org/obo/CHEBI_26708 |
T66 | 361-369 | Chemical | denotes | pyruvate | http://purl.obolibrary.org/obo/CHEBI_15361 |
T67 | 391-401 | Chemical | denotes | Penicillin | http://purl.obolibrary.org/obo/CHEBI_17334 |
T68 | 426-431 | Chemical | denotes | HEPES | http://purl.obolibrary.org/obo/CHEBI_46756 |
T69 | 529-533 | Chemical | denotes | DMSO | http://purl.obolibrary.org/obo/CHEBI_28262 |
T70 | 541-551 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
T71 | 560-571 | Chemical | denotes | favipiravir | http://purl.obolibrary.org/obo/CHEBI_134722 |
T72 | 593-602 | Chemical | denotes | tenofovir | http://purl.obolibrary.org/obo/CHEBI_134504|http://purl.obolibrary.org/obo/CHEBI_63625|http://purl.obolibrary.org/obo/CHEBI_63716 |
T75 | 610-631 | Chemical | denotes | fludarabine phosphate | http://purl.obolibrary.org/obo/CHEBI_63599 |
T76 | 622-631 | Chemical | denotes | phosphate | http://purl.obolibrary.org/obo/CHEBI_18367|http://purl.obolibrary.org/obo/CHEBI_26020|http://purl.obolibrary.org/obo/CHEBI_35780|http://purl.obolibrary.org/obo/CHEBI_43474 |
T80 | 656-684 | Chemical | denotes | chlorpromazine hydrochloride | http://purl.obolibrary.org/obo/CHEBI_3649 |
T81 | 656-670 | Chemical | denotes | chlorpromazine | http://purl.obolibrary.org/obo/CHEBI_3647 |
T82 | 671-684 | Chemical | denotes | hydrochloride | http://purl.obolibrary.org/obo/CHEBI_36807 |
T83 | 691-702 | Chemical | denotes | dalbavancin | http://purl.obolibrary.org/obo/CHEBI_82721 |
T84 | 703-716 | Chemical | denotes | hydrochloride | http://purl.obolibrary.org/obo/CHEBI_36807 |
T85 | 749-758 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
T86 | 766-775 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
T87 | 785-790 | Chemical | denotes | water | http://purl.obolibrary.org/obo/CHEBI_15377 |
T88 | 797-804 | Chemical | denotes | emetine | http://purl.obolibrary.org/obo/CHEBI_4781 |
T89 | 840-853 | Chemical | denotes | hydrochloride | http://purl.obolibrary.org/obo/CHEBI_36807 |
T90 | 861-870 | Chemical | denotes | ribavirin | http://purl.obolibrary.org/obo/CHEBI_63580 |
T91 | 879-902 | Chemical | denotes | oritavancin diphosphate | http://purl.obolibrary.org/obo/CHEBI_83305 |
T92 | 879-890 | Chemical | denotes | oritavancin | http://purl.obolibrary.org/obo/CHEBI_82699 |
T93 | 891-902 | Chemical | denotes | diphosphate | http://purl.obolibrary.org/obo/CHEBI_18361|http://purl.obolibrary.org/obo/CHEBI_33019 |
T95 | 905-928 | Chemical | denotes | Oseltamivir carboxylate | http://purl.obolibrary.org/obo/CHEBI_73139 |
T96 | 905-916 | Chemical | denotes | Oseltamivir | http://purl.obolibrary.org/obo/CHEBI_7798 |
T97 | 939-944 | Chemical | denotes | water | http://purl.obolibrary.org/obo/CHEBI_15377 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 1760-1785 | http://purl.obolibrary.org/obo/GO_1903901 | denotes | inhibit viral replication |
T4 | 1768-1785 | http://purl.obolibrary.org/obo/GO_0019079 | denotes | viral replication |
T5 | 1768-1785 | http://purl.obolibrary.org/obo/GO_0019058 | denotes | viral replication |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T25 | 0-193 | Sentence | denotes | SARS-CoV-2 virus, BetaCoV/Hong Kong/VM20001061/2020, was isolated from the nasopharynx aspirate and throat swab of a confirmed COVID-19 patient in Hong Kong using Vero E6 cells (ATCC CRL-1586). |
T26 | 194-433 | Sentence | denotes | Stock virus (107.25 TCID50/mL) was prepared after three serial passages in Vero E6 cells in infection media (DMEM supplemented with 4.5 g/L D-glucose, 100 mg/L sodium pyruvate, 2% FBS, 100,000 U/L Penicillin-Streptomycin, and 25 mM HEPES). |
T27 | 434-904 | Sentence | denotes | Compounds were sourced from MedChemExpress and Sigma-Aldrich and the stocks were prepared with DMSO (50 mM remdesivir, 100 mM favipiravir, 10 mM R-1479, 10 mM tenofovir, 10 mM fludarabine phosphate, 10 mM baloxavir, 10 mM chlorpromazine hydrochloride, 5 mM dalbavancin hydrochloride, 10 mM homoharringtonine, 10 mM lopinavir, 10 mM ritonavir) or with water (5 mM emetine dihydrochloride, 10 mM galidesivir hydrochloride, 50 mM ribavirin, 2.5 mM oritavancin diphosphate). |
T28 | 905-968 | Sentence | denotes | Oseltamivir carboxylate (10 mM in water) was provided by Roche. |
T29 | 969-1149 | Sentence | denotes | To evaluate the effect of compounds in vitro, Vero E6 cells were pre-treated with compounds diluted in infection media for 1 h prior to infection by SARS-CoV-2 virus at MOI = 0.02. |
T30 | 1150-1243 | Sentence | denotes | Antiviral compounds were maintained with the virus inoculum during the 2-h incubation period. |
T31 | 1244-1365 | Sentence | denotes | The inoculum was removed after incubation, and the cells were overlaid with infection media containing diluted compounds. |
T32 | 1366-1589 | Sentence | denotes | After 48 h incubation at 37 °C, supernatants were collected to quantify viral loads by TCID50 assay or quantitative real-time RT-PCR (TaqMan™ Fast Virus 1-Step Master Mix) following the methods described (Chu et al., 2020). |
T33 | 1590-1786 | Sentence | denotes | Four-parameter logistic regression (GraphPad Prism) was used to fit the dose-response curves and determined the 50% effective concentrations (EC50) of the compounds that inhibit viral replication. |
T34 | 1787-1920 | Sentence | denotes | Cytotoxicty of selected compounds was evaluated in Vero E6 cells using the CellTiter-Glo® Luminescent Cell Viability Assay (Promega). |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T109 | 0-10 | SP_7 | denotes | SARS-CoV-2 |
T110 | 11-16 | NCBITaxon:10239 | denotes | virus |
T111 | 75-86 | UBERON:0001728 | denotes | nasopharynx |
T112 | 100-106 | UBERON:0000341 | denotes | throat |
T113 | 127-135 | SP_7 | denotes | COVID-19 |
T114 | 163-167 | CL_6 | denotes | Vero |
T115 | 200-205 | NCBITaxon:10239 | denotes | virus |
T116 | 269-273 | CL_6 | denotes | Vero |
T117 | 334-343 | CHEBI:17634;CHEBI:17634 | denotes | D-glucose |
T118 | 354-369 | CHEBI:50144;CHEBI:50144 | denotes | sodium pyruvate |
T119 | 391-401 | CHEBI:17334;CHEBI:17334 | denotes | Penicillin |
T120 | 402-414 | CHEBI:17076;CHEBI:17076 | denotes | Streptomycin |
T121 | 426-431 | CHEBI:46756;CHEBI:46756 | denotes | HEPES |
T122 | 529-533 | CHEBI:51231;CHEBI:51231 | denotes | DMSO |
T123 | 541-551 | DG_28 | denotes | remdesivir |
T124 | 560-571 | CHEBI:119915;CHEBI:119915;DG_17;NCBITaxon:31032 | denotes | favipiravir |
T125 | 593-602 | CHEBI:50694;CHEBI:50694 | denotes | tenofovir |
T126 | 610-631 | CHEBI:63599;CHEBI:63599 | denotes | fludarabine phosphate |
T127 | 639-648 | CHEBI:3213;CHEBI:3213;NCBITaxon:10442 | denotes | baloxavir |
T128 | 656-684 | CHEBI:3649;CHEBI:3649 | denotes | chlorpromazine hydrochloride |
T129 | 691-702 | CHEBI:82721;CHEBI:82721 | denotes | dalbavancin |
T130 | 703-716 | CHEBI:36807;CHEBI:36807 | denotes | hydrochloride |
T131 | 749-758 | CHEBI:31781;CHEBI:31781;DG_23 | denotes | lopinavir |
T132 | 766-775 | CHEBI:45409;CHEBI:45409;DG_30 | denotes | ritonavir |
T133 | 785-790 | CHEBI:15377;CHEBI:15377 | denotes | water |
T134 | 797-804 | CHEBI:4781;CHEBI:4781 | denotes | emetine |
T135 | 805-820 | CHEBI:50488;CHEBI:50488 | denotes | dihydrochloride |
T136 | 828-839 | DG_19 | denotes | galidesivir |
T137 | 840-853 | CHEBI:36807;CHEBI:36807 | denotes | hydrochloride |
T138 | 861-870 | CHEBI:63580;CHEBI:63580;DG_29 | denotes | ribavirin |
T139 | 879-890 | CHEBI:82699;CHEBI:82699 | denotes | oritavancin |
T140 | 905-916 | CHEBI:7798;CHEBI:7798 | denotes | Oseltamivir |
T141 | 939-944 | CHEBI:15377;CHEBI:15377 | denotes | water |
T142 | 995-1004 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
T143 | 1015-1019 | CL_6 | denotes | Vero |
T144 | 1051-1060 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
T145 | 1118-1128 | SP_7 | denotes | SARS-CoV-2 |
T146 | 1129-1134 | NCBITaxon:10239 | denotes | virus |
T147 | 1160-1169 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
T148 | 1195-1200 | NCBITaxon:10239 | denotes | virus |
T149 | 1355-1364 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
T150 | 1438-1443 | NCBITaxon:10239 | denotes | viral |
T151 | 1533-1536 | CHEBI:60004;CHEBI:60004 | denotes | Mix |
T152 | 1745-1754 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
T153 | 1768-1773 | NCBITaxon:10239;GO:0006260 | denotes | viral |
T154 | 1774-1785 | GO:0006260 | denotes | replication |
T155 | 1811-1820 | CHEBI:36357;CHEBI:36357 | denotes | compounds |
T156 | 1838-1842 | CL_6 | denotes | Vero |
T51394 | 50-59 | CHEBI:36357;CHEBI:36357 | denotes | 0, was is |
T4039 | 71-81 | DG_28 | denotes | the nasoph |
T15138 | 83-92 | CHEBI:31781;CHEBI:31781;DG_23 | denotes | ynx aspir |
T51669 | 117-124 | CHEBI:4781;CHEBI:4781 | denotes | confirm |
T58177 | 125-140 | CHEBI:50488;CHEBI:50488 | denotes | d COVID-19 pati |
T19301 | 163-173 | SP_7 | denotes | Vero E6 ce |
T37435 | 174-185 | GO:0006260 | denotes | ls (ATCC CR |
T65481 | 189-193 | CL_6 | denotes | 86). |
T20928 | 280-289 | CHEBI:36357;CHEBI:36357 | denotes | ls in inf |
T40645 | 335-344 | CHEBI:63580;CHEBI:63580;DG_29 | denotes | -glucose, |
T63738 | 346-356 | CHEBI:119915;CHEBI:119915;DG_17;NCBITaxon:31032 | denotes | 00 mg/L so |
T87956 | 358-369 | CHEBI:7798;CHEBI:7798 | denotes | um pyruvate |
T21919 | 374-383 | CHEBI:3213;CHEBI:3213;NCBITaxon:10442 | denotes | FBS, 100, |
T55558 | 432-442 | SP_7 | denotes | . Compound |
T14223 | 443-448 | NCBITaxon:10239 | denotes | were |
T47691 | 504-514 | DG_28 | denotes | tocks were |
T481 | 521-522 | CHEBI:17865;CHEBI:17865 | denotes | e |
T933 | 522-523 | CHEBI:50217;CHEBI:50217 | denotes | d |
T48640 | 523-528 | CHEBI:48819;CHEBI:48819 | denotes | with |
T76259 | 541-550 | CHEBI:22260;CHEBI:22260;NCBITaxon:10508 | denotes | remdesivi |
T96701 | 592-597 | SP_6;NCBITaxon:9606 | denotes | teno |
T77315 | 598-611 | NCBITaxon:11118 | denotes | ovir, 10 mM f |
T62577 | 613-617 | NCBITaxon:10359 | denotes | dara |
T40572 | 627-631 | NCBITaxon:10359 | denotes | hate |
T50277 | 638-646 | SP_10 | denotes | baloxav |
T73620 | 648-656 | SP_9 | denotes | , 10 mM |
T4950 | 662-672 | SP_7 | denotes | romazine h |
T80102 | 796-806 | SP_7 | denotes | emetine d |
T5072 | 830-835 | NCBITaxon:10239 | denotes | lides |
T15145 | 927-937 | DG_28 | denotes | e (10 mM i |
T10448 | 960-970 | SP_7 | denotes | y Roche. T |
T83644 | 971-976 | NCBITaxon:10239 | denotes | eval |
T64090 | 1019-1024 | NCBITaxon:10239 | denotes | E6 c |
T4487 | 1075-1080 | NCBITaxon:10239 | denotes | ectio |
T17071 | 1129-1139 | DG_28 | denotes | virus at M |
T96477 | 1290-1295 | PR:000000125 | denotes | the |
T1195 | 1301-1306 | NCBITaxon:39107 | denotes | were |
T40045 | 1307-1316 | NCBITaxon:9606 | denotes | verlaid w |
T96720 | 1317-1322 | NCBITaxon:10239 | denotes | th in |
T66189 | 1377-1387 | DG_28 | denotes | incubation |
T25830 | 1519-1529 | SP_7 | denotes | 1-Step Mas |
T29703 | 1623-1633 | DG_28 | denotes | n (GraphPa |
T57743 | 1641-1650 | CHEBI:22260;CHEBI:22260 | denotes | was used |
T34401 | 1662-1673 | DG_19 | denotes | dose-respon |
T4604 | 1689-1710 | CHEBI:63599;CHEBI:63599 | denotes | termined the 50% effe |
T17962 | 1715-1724 | CHEBI:60783;CHEBI:60783 | denotes | concentr |
T44260 | 1736-1746 | DG_17;NCBITaxon:31032 | denotes | ) of the c |
T87537 | 1748-1757 | DG_29 | denotes | pounds th |
T38687 | 1783-1788 | NCBITaxon:10239;GO:0006260 | denotes | on. C |
T88567 | 1789-1801 | GO:0006260 | denotes | totoxicty of |
T50657 | 1835-1844 | CHEBI:60783;CHEBI:60783 | denotes | in Vero E |
T13669 | 1863-1870 | GO:0008152 | denotes | ellTite |